tiprankstipranks
Advertisement
Advertisement

XLO Stock Latest News

Xilio Therapeutics files $250M mixed securities shelf
The FlyXilio Therapeutics files $250M mixed securities shelf
12d ago
XLO
Xilio announces new preclinical data for XTX601 at AACR
PremiumThe Fly
Xilio announces new preclinical data for XTX601 at AACR
1M ago
XLO
Xilio Therapeutics Announces Board Changes and Committee Leadership
PremiumCompany Announcements
Xilio Therapeutics Announces Board Changes and Committee Leadership
1M ago
8K
XLO
Xilio Therapeutics appoints Blanchard to its Board of Directors
PremiumThe Fly
Xilio Therapeutics appoints Blanchard to its Board of Directors
1M ago
XLO
Upcoming Stock Splits This Week (March 16–20, 2026) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (March 16–20, 2026) – Stay Invested
2M ago
XLO
CLIR
Xilio Therapeutics Inc trading halted, news pending
PremiumThe FlyXilio Therapeutics Inc trading halted, news pending
2M ago
XLO
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
Premium
Company Announcements
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
2M ago
8K
XLO
Xilio Therapeutics announces 1-for-14 reverse stock split
Premium
The Fly
Xilio Therapeutics announces 1-for-14 reverse stock split
2M ago
XLO
Xilio Therapeutics Updates Investor Presentation on I-O Strategy
PremiumCompany Announcements
Xilio Therapeutics Updates Investor Presentation on I-O Strategy
3M ago
8K
XLO
Xilio Therapeutics announces inducement grants
PremiumThe Fly
Xilio Therapeutics announces inducement grants
3M ago
XLO
XLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
XLO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
XLO
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
PremiumCompany Announcements
Xilio Therapeutics Shareholders Approve Flexible Reverse Stock Split
3M ago
8K
XLO
Xilio Therapeutics Prices Pre-Funded Warrant Offering Financing
PremiumCompany AnnouncementsXilio Therapeutics Prices Pre-Funded Warrant Offering Financing
3M ago
8K
XLO
Xilio Therapeutics Announces Leadership Transition and Pipeline Updates
Premium
Company Announcements
Xilio Therapeutics Announces Leadership Transition and Pipeline Updates
5M ago
8K
XLO
Xilio Therapeutics highlights upcoming milestones, corporate updates
Premium
The Fly
Xilio Therapeutics highlights upcoming milestones, corporate updates
5M ago
XLO
Xilio Therapeutics Extends Cash Runway Into 2027
PremiumCompany Announcements
Xilio Therapeutics Extends Cash Runway Into 2027
5M ago
8K
XLO
Xilio Therapeutics Approves 2025 Stock Incentive Plan
PremiumCompany Announcements
Xilio Therapeutics Approves 2025 Stock Incentive Plan
6M ago
8K
XLO
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
PremiumCompany Announcements
Xilio Therapeutics Reports Revenue Growth Amidst Challenges
6M ago
XLO
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
PremiumThe Fly
Xilio Therapeutics expects cash to fund operations into Q1 of 2027
6M ago
XLO
Xilio Therapeutics reports Q3 EPS (11c) vs (22c) last year
PremiumThe FlyXilio Therapeutics reports Q3 EPS (11c) vs (22c) last year
6M ago
XLO
Xilio Therapeutics presents new data across portfolio at SITC
Premium
The Fly
Xilio Therapeutics presents new data across portfolio at SITC
7M ago
XLO
Xilio Therapeutics announces new data on Phase 2 trial of vilastobart
Premium
The Fly
Xilio Therapeutics announces new data on Phase 2 trial of vilastobart
7M ago
XLO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >